UK developed vaccine hailed ‘highly effective’
A Coronavirus vaccine developed in the UK can prevent 70.4% of people from getting Covid-19 and up to 90% if a lower dose is used, according to data.
The trial looked at two different dosing regimens. A half dose of the vaccine followed by a full dose at least one month apart was 90% effective.
A second regimen using two full doses one month apart was 62% effective. The combined results showed an average efficacy rate of 70%.
Oxford University and AstraZeneca have announced their jab is effective in preventing many people getting ill and it has been shown to work in different age groups, including the elderly.
There are early indications it might also help stop the spread of the disease.
Sarah Gilbert, professor of vaccinology at the University of Oxford, said:
“The announcement today takes us another step closer to the time when we can use vaccines to bring an end to the devastation caused by [Covid-19]”.
“We will continue to work to provide the detailed information to regulators”.
“It has been a privilege to be part of this multi-national effort, which will reap benefits for the whole world”.
UK officials have ordered 100,000,000 doses of the Oxford AstraZeneca vaccine.
Boris Johnson says the vaccine results are “increasingly exciting”.